Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 mayo 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. From Bare to Covered. 15-year single center experience and follow-up in trans-catheter stent implantation for aortic coarctation

Gianfranco Butera MD, PhD1,*, João Luiz Langer Manica MD, PhD2, Davide Marini MD1, Luciane Piazza MD, MSC1, Massimo Chessa MD, PhD1, Raul Ivo Rossi Filho MD, MSC2, Rogério E. Sarmento Leite MD, PhD2 andMario Carminati MD

Background: Bare stents has become the first line therapy for aortic coarctation. Covered stents has been reported more recently in clinical practice.

01 mayo 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: Implications of varying definitions of contrast-induced nephropathy

Davide Capodanno MD, PHD1,*, Margherita Ministeri MD1, Silvia Cumbo MD1, Veronica Dalessandro MD1 andCorrado Tamburino MD, PHD1,2

Objectives: Whether predicting the risk of early serum creatinine rise using the ratio of the volume of contrast media administered to the estimated creatinine clearance (V/CrCl) is applicable to the broader definition of contrast-induced nephropathy (CIN) (≥0.5 mg/dL absolute and/or 25% relative increase from baseline serum creatinine) is unknown.

01 mayo 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Comparison of abluminal biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents in the treatment of coronary bifurcations

Charis Costopoulos MD1,2,3, Azeem Latib MD1,2, Toru Naganuma MD1,2, Alessandro Sticchi MD1, Santo Ferrarello MD1, Damiano Regazzoli MD1, Alaide Chieffo MD1, Filippo Figini MD1, Mauro Carlino MD1, Matteo Montorfano MD1, Charbel Naim MD1, Masanori Kawaguchi MD1,2, Argyrios Gerasimou MD1, Francesco Giannini MD1, Cosmo Godino MD1 andAntonio Colombo MD1,2,*

Objectives: To compare biodegradable polymer biolimus-eluting (BES) with abluminal drug elution and durable polymer everolimus-eluting (EES) stents in the treatment of bifurcation lesions.

01 mayo 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis

Mohammad Almalla MD, Jörg Schröder MD, Verena Pross MSC, Nikolaus Marx MD andRainer Hoffmann MD*

Objective: Drug-eluting stent (DES) implantation is a very effective treatment of bare-metal stent–in-stent restenosis (BMS–ISR). Therapeutic options for drug-eluting stent–in-stent restenosis (DES–ISR) are less well defined, as there are only few data on safety and effectiveness of interventional modalities. This study compared the 1-year clinical outcome after the use of drug-eluting balloon (DEB) to second-generation everolimus-eluting stent (EES) for treatment of DES–ISR.

01 mayo 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation

Hae-Geun Song MD, Soo-Jin Kang MD, PhD, Jung-Min Ahn MD, Won-Jang Kim MD, Jong-Young Lee MD, Duk-Woo Park MD, PhD, Seung-Whan Lee MD, PhD, Young-Hak Kim MD, PhD, Cheol Whan Lee MD, PhD, Seong-Wook Park MD, PhD andSeung-Jung Park MD, PhD*

Objectives and Background: The impact of underexpansion and minimal stent area (MSA) criteria in the second generation drug-eluting stents (DES) has not been addressed yet.

01 abril 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Safety of percutaneous left atrial appendage closure with the amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation

Jens Wiebe MD, Stefan Bertog MD, Jennifer Franke MD, Olga Wettstein MD, Katharina Lehn MD, Ilona Hofmann MD, Laura Vaskelyte MD andHorst Sievert MD*

Objective: To evaluate the safety of percutaneous left atrial appendage (LAA) closure with the Amplatzer Cardiac Plug (ACP) in patients with nonvalvular atrial fibrillation (AF) who are not eligible for oral anticoagulation with warfarin.

01 abril 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve

Eulogio García MD1, Patricia Martín MD1,*, Rosana Hernández MD1, Victor Rodríguez MD2, Abelardo Fernández MD2, Vasco Gama MD3, Carlos Almería MD1 andCarlos Macaya MD1

Objectives: Balloon valvuloplasty (BV) before transcatheter aortic implantation has been thought to be mandatory before the valve is implanted. We have explored the feasibility and safety of direct implantation of balloon expandable Edwards SAPIEN XT valve without prior balloon dilatation.

01 abril 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Left ventricular end-diastolic pressure as an independent predictor of outcome during balloon aortic valvuloplasty

Roberto J. Cubeddu MD1,2,*, Creighton W. Don MD2,3, Sofia A. Horvath MD1, Pritha P. Gupta MD2, Ignacio Cruz-Gonzalez MD3, Christian Witzke MD3, Ignacio Inglessis MD3 andIgor F. Palacios MD3

Objectives: In this study, we examined the predictive value of the left ventricular end-diastolic pressure (LVEDP) in patients undergoing balloon aortic valvuloplasty (BAV)

01 abril 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Ductal spasm during performance of transcatheter ductal occlusion

Sarosh P. Batlivala MD1,2,3,4,*, Andrew C. Glatz MD, MSCE1,2, Matthew J. Gillespie MD1,2, Yoav Dori MD, PHD1,2 andJonathan J. Rome MD1,2

Objectives: Transcatheter patent ductus arteriosus (PDA) occlusion is a staple of pediatric catheterization laboratories. We present the phenomenon of significant PDA spasm to prevent failure to occlude a hemodynamically significant duct.

01 abril 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Reducing iodinated contrast volume by manipulating injection pressure during coronary angiography

David M. Kaye MBBS, PhD, FRACP, FACC1,2,*, Dion Stub MBBS, FRACP1,2, Vivian Mak RN1, Tuan Doan BS3 andStephen J. Duffy MBBS, PhD, FRACP, MRCP1

Objective: To evaluate the impact of a device-mediated modification of the injection pressure profile on iodinated contrast volumes during coronary angiography and percutaneous coronary intervention (PCI).

01 abril 2014

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. Procedural variation in the performance of primary percutaneous coronary intervention for ST-elevation myocardial infarction: A SCAI-based survey study of US interventional cardiologists

Austin Chiang MD, Hemal Gada MD, MBA, Susheel K. Kodali MD, Michael S. Lee MD, Allen Jeremias MD, Duane S. Pinto MD, MPH, Sripal Bangalore MD, MHA, Robert W. Yeh MD, MSc, Timothy D. Henry MD, Georgina Lopez-Cruz BS, MSHA, Roxana Mehran MD andAjay J. Kirtane MD, SM*

Background: Great strides have been made in improving outcomes for patients with ST-elevation myocardial infarction (STEMI), predominately through initiatives focusing upon improving clinical processes “upstream” of percutaneous coronary intervention (PCI). The actual step-by-step mechanics of diagnostic angiography during STEMI and other aspects of the PCI procedure itself have received relatively little attention.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.